Hydroxychloroquine: Pharma firms increase 'HCQ' production to meet demand
Assuring that the country has adequate supply of the anti-malaria tablets 'Hydroxychloroquine' for both domestic and export demand along with other key medicines, the Indian Pharmaceutical Alliance (IPA) on Sunday said that pharma companies are ramping up production of the key medicines to meet demand.
On March 25, India had banned the export of Hydroxychloroquine. Reuters photo.